IDiyas

For the Inventor, By the Inventor

Sudbury, MA, United States of America

Stephen H Ip

USPTO Granted Patents = 28

 

Average Co-Inventor Count = 5.7

ph-index = 13

Forward Citations = 486(Granted Patents)


Location History:

  • Framingham, MA (US) (1989 - 2001)
  • Sudbury, MA (US) (1993 - 2001)

Company Filing History:

goldMedal18 out of 24 
 
T Cell Sciences, Inc.
 patents
silverMedal6 out of 2,961 
 
Harvard College
 patents
bronzeMedal6 out of 155 
 
University of Mississippi
 patents
4. 5 out of 3,682 
 
The Johns Hopkins University
 patents
5. 5 out of 1,370 
 
The Brigham and Women's Hospital, Inc.
 patents
6. 5 out of 1,206 
 
Dana-farber-cancer Institute Inc.
 patents
7. 4 out of 46 
 
Astra Ab
 patents
8. 2 out of 20 
 
Avant Immunotherapeutics, Inc.
 patents
9. 2 out of 6 
 
T Cell Diagnostics, Inc.
 patents
10. 1 out of 1 
 
Dana Farber Cancer Institute & T Cell Diagnostics, Inc.
 patent
11. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2001

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents
1. 6316604 - Human C3b/C4b receptor (CR1) (2001-11-13),
2. 6313263 - &ggr;, &dgr; T cell receptor and methods for detection (2001-11-06),
3. 6171799 - Monoclonal antibodies reactive with defined regions of the T cell antigen receptor (2001-01-09),
4. 6048526 - Monoclonal antibodies reactive with defined regions of the T cell (2000-04-11),
5. 5981481 - Human C3b/C4b receptor (CR1) (1999-11-09),
6. 5980892 - Monoclonal antibodies reactive with defined regions of the T cell (1999-11-09),
7. 5976533 - Monoclonal antibodies reactive with defined regions of the T cell (1999-11-02),
8. 5856297 - Human C3b/C4b receptor (CR1) (1999-01-05),
9. 5808109 - Compounds that inhibit complement and/or suppress immune activity (1998-09-15),
10. 5656659 - Compounds which inhibit complement and/or suppress immune activity (1997-08-12),
11. 5601822 - .gamma., .delta. T cell receptor and methods for detection (1997-02-11),
12. 5506247 - Compounds that inhibit complement and/or suppress immune activity (1996-04-09),
13. 5472939 - Method of treating complement mediated disorders (1995-12-05),
14. 5436319 - Cell free T cell antigen receptor beta chain and its clinical utilities (1995-07-25),
15. 5401767 - Compounds which inhibit complement and/or suppress immune activity (1995-03-28),

Title: The Innovative Journey of Stephen H Ip

Introduction: Stephen H Ip, a talented inventor hailing from Sudbury, MA (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Stephen H Ip's latest patents showcase his prowess in the field of technology, with a focus on advancements in artificial intelligence and renewable energy solutions.

Career Highlights: Throughout his illustrious career, Stephen H Ip has been recognized for his exceptional work in developing cutting-edge technologies that have revolutionized various industries. His dedication to innovation has led to the creation of numerous groundbreaking inventions.

Collaborations: Stephen H Ip has collaborated with leading tech companies and research institutions to further his inventions and bring them to the market. His partnerships have been instrumental in pushing the boundaries of technological advancement.

Conclusion: Stephen H Ip's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…